Business
Glenmark Pharmaceuticals Q4 Result FY26: Net Profit Soars 64x to ₹301 Crore as Company Becomes Debt Free
The Indian pharmaceutical sector has witnessed several remarkable turnaround stories over the years, but Glenmark Pharmaceuticals may have just delivered…